PPIA and infection: Treatment with CsA, a CypA inhibitor, relieves the pre-integration block in mouse cells (which might implicate an effect of CypA on HIV-1 CA), but even in the presence of CsA, post-integration defects that are independent of CyclinT1, a factor known to be necessary for HIV to infection mouse cells, still remain (157).